Vaxcyte, Inc. (PCVX)
45.35
-0.71
(-1.54%)
USD |
NASDAQ |
Jan 08, 16:00
45.35
0.00 (0.00%)
After-Hours: 20:00
Vaxcyte Market Cap: 5.937B for Jan. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 143.62B |
| Novavax, Inc. | 1.193B |
| Thermo Fisher Scientific, Inc. | 227.81B |
| Moderna, Inc. | 13.23B |
| Eli Lilly & Co. | 970.77B |
Market Cap Related Metrics
| PEG Ratio | -1.767 |
| Price to Book Value | 2.052 |
| Price | 45.35 |
| Earnings Yield | -10.85% |
| PEGY Ratio | -1.767 |